CALL FOR PAPERS

CERTIFICATE

IMPACT FACTOR 2018

Subject Area

  • Life Sciences / Biology
  • Architecture / Building Management
  • Asian Studies
  • Business & Management
  • Chemistry
  • Computer Science
  • Economics & Finance
  • Engineering / Acoustics
  • Environmental Science
  • Agricultural Sciences
  • Pharmaceutical Sciences
  • General Sciences
  • Materials Science
  • Mathematics
  • Medicine
  • Nanotechnology & Nanoscience
  • Nonlinear Science
  • Chaos & Dynamical Systems
  • Physics
  • Social Sciences & Humanities

Why Us? >>

  • Open Access
  • Peer Reviewed
  • Rapid Publication
  • Life time hosting
  • Free promotion service
  • Free indexing service
  • More citations
  • Search engine friendly

Plagiarism Detection

IJCR is following an instant policy on rejection those received papers with plagiarism rate of more than 20%. So, All of authors and contributors must check their papers before submission to making assurance of following our anti-plagiarism policies.

Use of statins in india: a survey to understand the prescribing patterns of physicians in india- score study

Author: 
Narasingan, S.N., Anirudha V. Potey, Shahu Ingole, Anoop Hajare and Swati Naik
Subject Area: 
Physical Sciences and Engineering
Abstract: 

Background: Hyperlipidemia is a modifiable risk factor for cardiovascular disease (CVD) and is primarily treated by statins. The present survey was conducted to understand the prescribing practices of physicians and cardiologists in managing patients of dyslipidemia with various statins. Methods: This was a prospective, cross sectional, questionnaire-based survey of Indian physicians and cardiologists managing the patients of dyslipidemia with statins. The questionnaire consisting of 10 questions related to the use of statins in the management of dyslipidemia in real-world clinical settings was prepared, validated and then administered to physicians and cardiologists attending CSI 2016. Results: Responses from 358 physicians and cardiologists were received. Compared to other statins, most physicians experienced maximum reduction in the low-density lipoprotein cholesterol (56.7%), triglycerides (47.2%) and maximum increase in high-density lipoprotein cholesterol (48.3%) with rosuvastatin. Rosuvastatin was reported as the most preferred statin by the physicians in their clinical practice for primary prevention (50.6%) and secondary prevention (49.4%) of CVD followed by atorvastatin (38.5% and 31%, respectively). Physicians preferred rosuvastatin over atorvastatin in patients with diabetes mellitus or metabolic syndrome (53.4% vs 27.7%), while atorvastatin was preferred over rosuvastatin in patients with chronic kidney disease (44.4% vs 32.4%) and chronic heart failure (46.9% vs 34.6%). Amongst the statins, the highest dose tolerable was that of rosuvastatin 40 mg (39.9%). Conclusion: The survey findings suggest that rosuvastatin was the most preferred stat in among cardiologists and physicians, followed by atorvastatin in the management of patients with hyperlipidaemia and for primary and secondary prevention of CVD.

PDF file: 

IJMCE RECOMMENDATION

ONLINE PAYPAL PAYMENT

CURRENT ISSUE

NEWS

CHIEF EDITOR
Rosane Cavalcante Fragoso, Brasil
ASSOCIATE CHIEF EDITOR

   

Jean-Marc SABATIER
Chief Scientific Officer and Head of a Research Group
France

Advantages of IJCR

  • Rapid Publishing
  • Professional publishing practices
  • Indexing in leading database
  • High level of citation
  • High Qualitiy reader base
  • High level author suport

EDITORIAL BOARD

Luai Farhan Zghair
Iraq
Hasan Ali Abed Al-Zu’bi
Jordanian
Fredrick OJIJA
Tanzanian
Firuza M. Tursunkhodjaeva
Uzbekistan
Faraz Ahmed Farooqi
Saudi Arabia
Eric Randy Reyes Politud
Philippines
Elsadig Gasoom FadelAlla Elbashir
Sudan
Eapen, Asha Sarah
United State
Dr.Arun Kumar A
India
Dr. Zafar Iqbal
Pakistan
Dr. SHAHERA S.PATEL
India
Dr. Ruchika Khanna
India
Dr. Recep TAS
Turkey
Dr. Rasha Ali Eldeeb
Egypt
Dr. Pralhad Kanhaiyalal Rahangdale
India
DR. PATRICK D. CERNA
Philippines
Dr. Nicolas Padilla- Raygoza
Mexico
Dr. Mustafa Y. G. Younis
Libiya
Dr. Muhammad shoaib Ahmedani
Saudi Arabia
DR. MUHAMMAD ISMAIL MOHMAND
United State
DR. MAHESH SHIVAJI CHAVAN
India
DR. M. ARUNA
India
Dr. Lim Gee Nee
Malaysia
Dr. Jatinder Pal Singh Chawla
India
DR. IRAM BOKHARI
Pakistan
Dr. FARHAT NAZ RAHMAN
Pakistan
Dr. Devendra kumar Gupta
India
Dr. ASHWANI KUMAR DUBEY
India
Dr. Ali Seidi
Iran
Dr. Achmad Choerudin
Indonesia
Dr Ashok Kumar Verma
India
Thi Mong Diep NGUYEN
France
Dr. Muhammad Akram
Pakistan
Dr. Imran Azad
Oman
Dr. Meenakshi Malik
India
Aseel Hadi Hamzah
Iraq
Anam Bhatti
Malaysia
Md. Amir Hossain
Bangladesh
Ahmet İPEKÇİ
Turkey
Mirzadi Gohari
Iran